Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Kaat Durinck

7 Results

As Promotor

01 January 2022 → Ongoing

Building a next-generation precision oncology platform for childhood cancer

Funding: Regional and community funding: Special Research Fund

As Copromotor

01 October 2019 → Ongoing

The PHF6 - TLX1 cooperativity and the IL7R-JAK3 signaling axis as drug target in PHF6 deficient TALL.

Funding: Regional and community funding: Special Research Fund

As Fellow

01 October 2016 → 30 September 2019

Identification of novel therapeutic targets through multi-level (epi) genomic landscaping of replicative stress resistant neuroblastoma

Funding: Regional and community funding: Special Research Fund

01 January 2018 → 31 December 2018

The chromatin modifier BRD3 as a key novel player in DNA repair and vulnerable therapeutic target in neuroblastoma

Funding: Research Foundation - Flanders (FWO)

01 January 2015 → 31 December 2015

The PHF6 - TLX1 cooperativity and the IL7R-JAK3 signaling axis as drug target in PHF6 deficient T-ALL

Funding: Research Foundation - Flanders (FWO)

01 October 2018 → 31 August 2021

The role of BRCA1 as oncogenic replicative stress resistor in MYCN driven neuroblastoma

Funding: Research Foundation - Flanders (FWO)

01 October 2010 → 05 January 2016

Unraveling the role of PHF6 in normal T cell development and T-cell acute lymphoblastic leukemia

Funding: Regional and community funding: IWT/VLAIO

As Contact person

01 January 2022 → Ongoing

Building a next-generation precision oncology platform for childhood cancer